Standard BioTools Inc
NASDAQ:LAB

Watchlist Manager
Standard BioTools Inc Logo
Standard BioTools Inc
NASDAQ:LAB
Watchlist
Price: 1.71 USD 5.56% Market Closed
Market Cap: 636.6m USD
Have any thoughts about
Standard BioTools Inc?
Write Note

Intrinsic Value

LAB's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one LAB stock under the Base Case scenario is 1.09 USD. Compared to the current market price of 1.71 USD, Standard BioTools Inc is Overvalued by 36%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LAB Intrinsic Value
1.09 USD
Overvaluation 36%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Standard BioTools Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for LAB cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about LAB?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Standard BioTools Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Standard BioTools Inc

Provide an overview of the primary business activities
of Standard BioTools Inc.

What unique competitive advantages
does Standard BioTools Inc hold over its rivals?

What risks and challenges
does Standard BioTools Inc face in the near future?

Summarize the latest earnings call
of Standard BioTools Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Standard BioTools Inc.

Provide P/S
for Standard BioTools Inc.

Provide P/E
for Standard BioTools Inc.

Provide P/OCF
for Standard BioTools Inc.

Provide P/FCFE
for Standard BioTools Inc.

Provide P/B
for Standard BioTools Inc.

Provide EV/S
for Standard BioTools Inc.

Provide EV/GP
for Standard BioTools Inc.

Provide EV/EBITDA
for Standard BioTools Inc.

Provide EV/EBIT
for Standard BioTools Inc.

Provide EV/OCF
for Standard BioTools Inc.

Provide EV/FCFF
for Standard BioTools Inc.

Provide EV/IC
for Standard BioTools Inc.

Show me price targets
for Standard BioTools Inc made by professional analysts.

What are the Revenue projections
for Standard BioTools Inc?

How accurate were the past Revenue estimates
for Standard BioTools Inc?

What are the Net Income projections
for Standard BioTools Inc?

How accurate were the past Net Income estimates
for Standard BioTools Inc?

What are the EPS projections
for Standard BioTools Inc?

How accurate were the past EPS estimates
for Standard BioTools Inc?

What are the EBIT projections
for Standard BioTools Inc?

How accurate were the past EBIT estimates
for Standard BioTools Inc?

Compare the revenue forecasts
for Standard BioTools Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Standard BioTools Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Standard BioTools Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Standard BioTools Inc compared to its peers.

Compare the P/E ratios
of Standard BioTools Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Standard BioTools Inc with its peers.

Analyze the financial leverage
of Standard BioTools Inc compared to its main competitors.

Show all profitability ratios
for Standard BioTools Inc.

Provide ROE
for Standard BioTools Inc.

Provide ROA
for Standard BioTools Inc.

Provide ROIC
for Standard BioTools Inc.

Provide ROCE
for Standard BioTools Inc.

Provide Gross Margin
for Standard BioTools Inc.

Provide Operating Margin
for Standard BioTools Inc.

Provide Net Margin
for Standard BioTools Inc.

Provide FCF Margin
for Standard BioTools Inc.

Show all solvency ratios
for Standard BioTools Inc.

Provide D/E Ratio
for Standard BioTools Inc.

Provide D/A Ratio
for Standard BioTools Inc.

Provide Interest Coverage Ratio
for Standard BioTools Inc.

Provide Altman Z-Score Ratio
for Standard BioTools Inc.

Provide Quick Ratio
for Standard BioTools Inc.

Provide Current Ratio
for Standard BioTools Inc.

Provide Cash Ratio
for Standard BioTools Inc.

What is the historical Revenue growth
over the last 5 years for Standard BioTools Inc?

What is the historical Net Income growth
over the last 5 years for Standard BioTools Inc?

What is the current Free Cash Flow
of Standard BioTools Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Standard BioTools Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Standard BioTools Inc

Current Assets 480m
Cash & Short-Term Investments 394.7m
Receivables 32.4m
Other Current Assets 52.9m
Non-Current Assets 228.7m
PP&E 74.1m
Intangibles 130.3m
Other Non-Current Assets 24.3m
Current Liabilities 123.8m
Accounts Payable 12.6m
Accrued Liabilities 37.8m
Other Current Liabilities 73.5m
Non-Current Liabilities 74.7m
Long-Term Debt 299k
Other Non-Current Liabilities 74.4m
Efficiency

Earnings Waterfall
Standard BioTools Inc

Revenue
136.3m USD
Cost of Revenue
-72.7m USD
Gross Profit
63.6m USD
Operating Expenses
-176.7m USD
Operating Income
-113.1m USD
Other Expenses
-51.5m USD
Net Income
-164.7m USD

Free Cash Flow Analysis
Standard BioTools Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

LAB Profitability Score
Profitability Due Diligence

Standard BioTools Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
ROE is Increasing
24/100
Profitability
Score

Standard BioTools Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

LAB Solvency Score
Solvency Due Diligence

Standard BioTools Inc's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
73/100
Solvency
Score

Standard BioTools Inc's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LAB Price Targets Summary
Standard BioTools Inc

Wall Street analysts forecast LAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LAB is 3.14 USD with a low forecast of 2.53 USD and a high forecast of 4.2 USD.

Lowest
Price Target
2.53 USD
48% Upside
Average
Price Target
3.14 USD
84% Upside
Highest
Price Target
4.2 USD
146% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for LAB?

Click here to dive deeper.

Dividends

Standard BioTools Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for LAB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

LAB News

Other Videos

Profile

Standard BioTools Inc Logo
Standard BioTools Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

632.6m USD

Dividend Yield

0%

Description

Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.

Contact

CALIFORNIA
South San Francisco
2 Tower Place, Suite 2000
+16502666000.0
www.fluidigm.com

IPO

2011-02-10

Employees

615

Officers

President, CEO & Director
Dr. Michael Egholm Ph.D.
Interim CFO & COO
Mr. Hanjoon Kim
Investor Relations
David Holmes
Chief Business Officer & Senior VP
Mr. Sean Mackay
Chief Medical Officer
Dr. Stephen A. Williams BS, MB, Ph.D.

See Also

Discover More
What is the Intrinsic Value of one LAB stock?

The intrinsic value of one LAB stock under the Base Case scenario is 1.09 USD.

Is LAB stock undervalued or overvalued?

Compared to the current market price of 1.71 USD, Standard BioTools Inc is Overvalued by 36%.

Back to Top